Home
Categories
EXPLORE
True Crime
Comedy
Sports
Society & Culture
Business
News
History
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/ca/34/c9/ca34c9f8-e74b-c686-78b9-b1635c5e046b/mza_16455365122741899899.jpg/600x600bb.jpg
Decera Clinical Education Oncology Podcast
Clinical Care Options
216 episodes
1 day ago
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
Show more...
Courses
Education,
Health & Fitness,
Medicine,
Science,
Life Sciences
RSS
All content for Decera Clinical Education Oncology Podcast is the property of Clinical Care Options and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
Show more...
Courses
Education,
Health & Fitness,
Medicine,
Science,
Life Sciences
https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/0052e8d7-042d-484b-b0c9-970d431e45d4/3000x3000/101246-ep-nec-tm-rfp-3000x3000.jpg?aid=rss_feed
Emerging DLL3-Targeted Therapies for Extrapulmonary Neuroendocrine Carcinomas
Decera Clinical Education Oncology Podcast
29 minutes 59 seconds
3 months ago
Emerging DLL3-Targeted Therapies for Extrapulmonary Neuroendocrine Carcinomas
Listen to Dr. Daniel Morgensztern and Dr. Jonathan Strosberg discuss the diagnosis, prognosis, and current limited treatment options for poorly differentiated extrapulmonary neuroendocrine carcinomas, followed by a discussion focusing on emerging DLL3-targeted therapies, including bispecific therapies, antibody–drug conjugates, and CAR T-cell therapies, and their potential roles in improving patient outcomes.
Decera Clinical Education Oncology Podcast
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.